Looks like the American college of cardiology is making a fortune off of Amgen and novartis. Selling the two companies on why all the reps have to pass this test. What a joke. Monitors walking around room as test is taken. Jesus.
How is the respiratory division going?? Is it on solid ground for 2015 and future? Im in the oncology division and hoping all divisions are fairly stable. Besides the Zolair and injectable antibiotic anything else on the horizon? thanks
It's all show. But doctors do want reps who know what they're talking about. That's become a rarity today as the quality of reps has deteriorated appreciably.
